Please login to the form below

Putting people and the planet first in 2020

Valid Insight go paperless to promote environmental sustainability within the pharmaceutical industry

At Valid Insight, we attend and participate in many conferences each year. We think it’s vital in helping us continue to be inspired and innovate, to share our insight and expertise, and in turn help others be inspired and continue to transform healthcare. Ultimately, we hope this contributes towards the common goal: improving health outcomes.

But, did you know that a typical conference can generate the equivalent of 170 trees worth of paper waste, and that the average attendee can take home as much as 5kg of paper? Reducing the amount of paper waste for a conference of 500 attendees can save over 90kg of wood, and with Valid Insight attending pharmaceutical industry events every year we decided to do something to promote environmental sustainability.

Our pledge to pass on plastic and paper

In 2020, we will find alternatives to paper in every area we can, and reduce our plastic use.

We’re always looking for ways to continuously improve our services and communication while minimising environmental impact. At this years’ ISPOR and BIO-Europe conferences we took the decision that our exhibition stand was to be made using as many recycled and reusable components as possible and would utilise low energy LED lighting. Those of you visiting our stand would have noticed that we went entirely paperless—we took the decision to have no brochures and no business cards, just good, interesting, discussions on offer for people interested in our products and services.

#TRAVELLESS™, #paperless

One way in which we already offer a greener option, is through TRAVELLESS, our virtual solution that provides an easy and compliant way to deliver effective strategy workshops online. It eliminates the need for paper resources, as everything is shared digitally, and as the meetings are conducted remotely, the carbon footprint is negligible, among other benefits. You can find out more about TRAVELLESS and its benefits, here.

Making 2020 our greenest year yet

We had a great 2019 and we appreciate that our green initiatives this year will be a tough act to follow. Therefore, we have been getting creative with our plans… We’ll reveal more in the New Year, but needless to say, we will be continuing to find more ways in which we can reduce our impact on the world we live in. So, moving forwards, we’ll be continuing to promote environmental sustainability in the way work and in our delivery models, and we’ll be encouraging our clients to do the same!

31st January 2020



Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

152-160 City Road
Kemp House
United Kingdom

Latest content on this profile

Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative to alternative treatments for successful market access. In this blog, we summarise the reasons for negative reimbursement decisions in 2017 and discuss common pitfalls manufacturers should avoid.
Valid Insight
Using TRAVELLESS™ to provide tailored pharmaceutical training
In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry.
Valid Insight
The vicious circle of pharmaceutical tendering
Pharmaceutical tendering and contracting has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s. In the 1990s, international institutions such as the World Health Organisation and the World Bank endorsed tendering as the preferred procurement process for drugs.
Valid Insight
The benefits of a expert-led market access strategy
In order to support effective decision making and deliver sustained returns in a complex, dynamic healthcare environment, pharmaceutical, biotech and medical device companies need an expert-led market access strategy that considers the changing nature of the real-life marketplace. These strategies should not only focus on achieving the commercial objectives for a product but also enable it to outperform competitors throughout the product life cycle.
Valid Insight